Results 151 to 160 of about 23,309 (224)

<i>In silico</i> evaluation of soursop (<i>Annona muricata</i>) leaf compound interactions with CYP450 and their potential impact on systemic cancer therapies. [PDF]

Toxicol Rep
Ballesteros-Ramírez R, Fuenmayor D, Martínez-Ramos N, Duque-Grisales E, Murillo R.   +4 more
europepmc   +1 more source

Understanding Atomoxetine Exposure Variability in Children and Adolescents With ADHD Through Population Pharmacokinetics. [PDF]

J Clin Pharmacol
Tobin KV, Pritchett A, Leeder JS, Gobburu J, Dunn A.   +4 more
europepmc   +1 more source

Effect of Individual and Combined Cytochrome P450 Activity Scores on Symptom Improvement and Side Effects in Youth Treated With Sertraline. [PDF]

Clin Transl Sci
Gerlach S, Maruf AA, Shaheen SM, McCloud R, Heintz M, McAusland L, Arnold PD, Bousman CA.   +7 more
europepmc   +1 more source

CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing. [PDF]

Pharmacogenomics J
Tašková I, Šafářová N, Hahn M.
europepmc   +1 more source

Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study. [PDF]

PLoS Negl Trop Dis
Corder RM, Puça MCSB, Prete CA, Ladeia WA, Rodrigues PT, Johansen IC, de Sousa TN, Ferreira MU, Mâncio Lima Cohort Study Working Group.   +8 more
europepmc   +1 more source